Lawrence M Kauvar

Larry Kauvar, PhD is a serial entrepreneur scientist who founded Trellis Bioscience where he serves as Senior VP, Chief Scientific Officer. He was previously the founder and Chief Scientific Officer of Telik, a public development stage small molecule drug company focused on oncology, and is a co-founder of Promedior, a private development stage biologics company focused on fibrotic diseases. He holds 60 US patents for drug discovery methods and tools as well as specific compounds. He is one of the inventors of CellSpot™, Trellis' core technology for discovery of native human monoclonal antibodies. Dr. Kauvar received his undergraduate degree in mathematics from Harvard in 1973, his PhD from Yale in Molecular Biophysics and Biochemistry in 1978, and conducted postdoctoral research at Caltech and UC San Francisco before founding Telik.